Don Hardison brings a broad private and public company background in both emerging and Fortune 500 companies. Most recently, Mr. Hardison was President, CEO of Biotheranostics, Inc, prior to their acquisition by Hologic. He was also Executive Vice President & Chief Operating Officer at Labcorp, and President and CEO of EXACT Sciences Corporation. Over the past 40 years, he also has held numerous leadership roles at Good Start Genetics, Quest Diagnostics and SmithKline Beecham (GlaxoSmithKline). He currently serves as a board member of several life sciences companies including mdxhealth, BioPorto, Cytek Biosciences, Arima Genomics, Geneoscopy and Decode Health. He holds a bachelor’s degree from the University of North Carolina, Chapel Hill.